The annual incidence of idiopathic intracranial hypertension (IIH) in the US is 0.9/100,000 persons, and 3.5/100,000 in females aged 15 to 44 years.[3][4] Among obese women aged 20 to 44 years who are ‚Č•20% over their ideal weight, the incidence is 19/100,000.[3] More than 90% of patients are obese, and >90% are women of childbearing age. Female preponderance and the association of obesity is true only for post-pubertal patients.[5] The mean age at diagnosis is about 30 years.[3] Idiopathic intracranial hypertension occurs throughout the world, with an estimated incidence of 1 to 3 per 100,000 population per year.[6] One crude annual incidence rate in Libya found idiopathic intracranial hypertension to be 2.2/100,000 and 21.4/100,000 in obese females aged 15 to 44 years.[7] In the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT), a US-based randomised controlled study involving 165 subjects with IIH and mild visual loss, all subjects were overweight, most were obese (88%), and most were female (98%).[8]

BMJ Best Practice is an evidence-based point of care tool for healthcare practitioners.

To continue reading and access all of BMJ Best Practice's pages you'll need to log in or start a free trial.

You can access through your institution if your hospital, university, trust or other institution provides access to BMJ Best Practice through either OpenAthens or Shibboleth.

Use of this content is subject to our disclaimer